Successful treatment of hemifacial spasm with selective facial nerve block using doxorubicin (adriamycin) under local anesthesia

Acta Oto-Laryngologica

Volumn 124, Issue 2, 2004, Pages 217-220

  Ito, Makoto ^a   Hasegawa, Mitsuhiro ^a   Hoshida, Sigeru ^a   Miwa, Takaki ^a   Furukawa, Mitsuru ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Abnormal facial movement; Chemical rhizotomy; Retrograde transport

Indexed keywords

CARBAMAZEPINE; DOXORUBICIN;

AGED; ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; BRAIN SURGERY; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; DRUG ADMINISTRATION ROUTE; ELECTROMYOGRAPHY; FACIAL NERVE; FACIAL NERVE SURGERY; FEMALE; GENERAL ANESTHESIA; HEMIFACIAL SPASM; HIGH RISK POPULATION; HUMAN; INTRANEURAL DRUG ADMINISTRATION; LOCAL ANESTHESIA; MINIMALLY INVASIVE SURGERY; NERVE BLOCK; NERVE FIBER GROWTH; NERVE STIMULATION; NEUROTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT DISEASE; RHIZOTOMY;

EID: 1642316255     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Jannetta PJ, Abbasy M, Maroon J, Ramos FM, Albin MS. Etiology and definitive microsurgical treatment of hemifacial spasm. J Neurosurg 1977; 47: 321-8.
2. Kuroki A, Møller AR. Facial nerve demyelination and vascular compression are both needed to induce facial hyperactivity: a study in rats. Acta Neurochir (Wien) 1994; 126: 149-57.
3. Møller AR. Hemifacial spasms: ephaptic transmission or hyperexcitability of the facial motor nucleus? Exp Neurol 1987; 98: 110-9.
4. Drummond GT, Hinz BJ. Botulinum toxin for blepharospasm and hemifacial spasm: stability of duration of effect and dosage over time. Can J Ophthalmol 2001; 36: 398-403.
5. Defazio G, Abbruzzese G, Girlanda P, Vacca L, Curra A, De Salvia, et al. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol 2002; 59: 418-20.
6. Bigotte L, Olsson Y. Retrograde transport of doxorubicin (adriamycin) in peripheral nerves of mice. Neurosci Lett 1982; 32: 217-21.
7. Cho ES. Toxic effects of adriamycin on the ganglia of the peripheral nervous system: a neuropathological study. J Neuropathol Exp Neurol 1977; 36: 907-15.
8. Kato S, Yamamoto T, Iwasaki Y, Niizuma H, Nakamura T, Suzuki J. Experimental retrograde adriamycin trigeminal sensory ganglionectomy. J Neurosurg 1988; 69: 760-5.
9. Bigotte L, Olsson Y. Cytotoxic effects of adriamycin on mouse hypoglossal neurons following retrograde axonal transport from the tongue. Acta Neuropathol 1983; 61: 161-8.
10. Bigotte L, Olsson Y. Degeneration of trigeminal ganglion neurons caused by retrograde axonal transport of doxorubicin. Neurology 1987; 37: 985-92.
11. Yamamoto T, Iwasaki Y, Konno H. Experimental sensory ganglionectomy by way of suicide axoplasmic transport. J Neurosurg 1984; 60: 108-14.
12. Wiley RG, Blessing WW, Reis DJ. Suicide transport: distribution of neurons by retrograde transport of ricin, abrin, and modeccin. Science 1982; 216: 889-90.
13. Yamamoto T, Iwasaki Y, Konno H. Retrograde axoplasmic transport of adriamycin: an experimental form of motor neuron disease? Neurology 1984; 34: 1299-304.
14. Yamamoto T, Iwasaki Y, Konno H. Primary degeneration of motor neurons by toxic lectins conveyed from the peripheral nerve. J Neurol Sci 1985; 70: 327-37.
15. Saiki M, Kondo A, Kinuta Y, Iwasaki K, Kobata H, Hasegawa K, et al. Treatment of intractable postherpetic neuralgia and blepharospasm: intraneural injection of adriamycin. No Shinkei Geka 1995; 23: 125-30 (in Japanese).
16. Wirtschafter JD, McLoon LK. Long-term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm. Ophthalmology 1998; 105: 342-6.
17. McLoon LK, Kirsch JD, Cameron S, Wirtschafter JD. Injection of doxorubicin into rabbit eyelid does not result in loss of facial motor neurons. Brain Res 1994; 28: 105-10.